Eugene Labs
PrivateLast Round
Corporate Funding
Apr 22, 2025
Total Funding Raised
$2.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Eugene Labs operates in Healthcare & Life Sciences and is based in Richmond. Its latest recorded funding round was a Corporate Funding round in April 2025.
Eugene Labs is a digital healthcare company that offers at-home genetic tests, in-app counseling, carrier testing, and proactive cancer risk assessments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Telemedicine, D2C Brands
Business Model
B2C
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eugene Labs Comparables
Compare Eugene Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DBG Health | 89% | |
| GeneScreen Counseling | 79% | |
| Nucleus Genomics | 78% |
For institutional investors. Book with your work email.
Eugene Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 22, 2025 | ||||
| Series A | Jan 18, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eugene Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALIAVIA Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
Monthly visitors increased 544% MoM, reaching 19.2K.
- Jun 21, 2026
Monthly visitors grew 128% MoM, reaching 15.5K.
For institutional investors. Book with your work email.
Eugene Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eugene Labs's valuation, stock price, and market status.
Is Eugene Labs a public or private company?
Eugene Labs is a private company.
What is the current stock price of Eugene Labs?
Eugene Labs is a private company, so its shares have no public market price. Caplight tracks Eugene Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eugene Labs worth (valuation)?
Valuation information for Eugene Labs is not publicly available.
Can I buy Eugene Labs stock?
Eugene Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eugene Labs's last funding round?
Eugene Labs's most recent funding round was Corporate Funding on April 22, 2025.
Who are the main investors in Eugene Labs?
Key investors in Eugene Labs include ALIAVIA Ventures.
Will Eugene Labs IPO soon?
No public IPO plans have been announced for Eugene Labs.
How can I track Eugene Labs secondary market activity?
Caplight tracks bids, offers, and trades in Eugene Labs's shares on secondary markets.